CHELSEY KOSIK: Open Payments
NPI 1962077958 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 6 payments from 3 companies in 2025. Trend: 2023 $341 · 2024 $367 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $102 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: DUPIXENT, NUCALA.
Industry payments across AL — which companies pay providers there.
